miliary mottling on chest radiography is seen in miliary tuberculosis, certain fungal infections, sarcoidosis, coal miner’s pneumoconiosis, silicosis, hemosiderosis, fibrosing alveolitis, acute extrinsic allergic alveolitis, pulmonary eosinophilic syndrome, pulmonary alveolar proteinosis, and rarely in hematogenous metastases from the primary cancers of the thyroid, kidney, trophoblasts, and so...

Small Cell Lung Cancer (SCLC) is a low-differentiated neuroendocrine tumor with rapid growth, early metastasis and sensitivity to radiotherapy chemotherapy. It highly recurrence rate. And there lacking effective treatment now. As an active research direction at present, anti-angiogenic drugs are not only widely used in non-small cell lung cancer other tumors, but also have certain effects small...

Immuno-oncology marked a therapeutic revolution in the treatment of cancer. Thanks to new strategy that aims awaken immune system fight cancer cells, there has been change clinical course advanced Non- Small Cell Lung Cancer (NSCLC). Our study aimed evaluate efficacy nivolumab monotherapy patients with stage IIIB/IV non-small cell lung beyond second line. The results showed progression-free sur...

Background: the aim of this study was to investigate the prognostic value of 18Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) parameters in both overall survival and progression-free survival in Stage I-III non-small cell lung cancer (NSCLC). Materials and Methods: In this retrospective study, 267 patients who were diagnosed as Stage I-III non-smal...

Introduction: Despite improvements in the diagnosis and treatment of lung cancer in the past two decades, it has remained the most common cause of death from cancer worldwide. Among all genes that are mutated in lung cancer, TP53 located on chromosome 17P13/1 has a significant diagnostic and prognostic value. TP53 mutations have been extensively studied in lung cancer and TP53 mutational spectr...

Background: The EML4-ALK fusion oncogene is found in 2 to 7% of all non-small cell lung cancers, most which are adenocarcinomas. These rare ALK-positive malignancies represent approximately 4% adenocarcinoma non-small-cell cancer; metastatic spread the breast exceedingly rare, with an incidence between 0.2-3% reported cases. Here we present a case cancer metastasizing first and then spine.